Washington D.C. -- J. A. Green & Company ("J. A. Green & Co." or the "Company") President Jeff Green published an opinion editorial (“op-ed”) in Defense News titled, “In Defense of the Defense Production Act.”
In the op-ed, Green addresses recent media coverage that questions the veracity and legitimacy of defense-related projects supported by funds appropriated under the Defense Production Act, Title III program. “Yes—funds from the Defense Production Act were used on projects other than those strictly related to health care. No—the projects in question were not fraudulent, arbitrary, or some feature of corrupt behavior,” Green says in the op-ed. “First and foremost: The Department of Health and Human Services has no active solicitations for offerors to submit DPA projects, having left that responsibility to DoD. Even if there were unmet or emerging requirements, the less than $1 billion spent by DoD from the CARES Act is more than offset by a $17 billion investment from HHS. Without direction from HHS, DoD did what it should do when given DPA funding: it moved quickly and decisively to secure important gaps and nodes in national security supply chains. This remains a national imperative, especially as the industrial base and the American workforce have been weakened by the pandemic.” J. A. Green & Co. has been helping businesses navigate the complexities of government since 2007. Jeff Green is a retired Air Force Colonel, former counsel for the House Armed Services Committee, and President of J. A. Green & Co., a Washington D.C. federal affairs consulting firm. The complete op-ed may be found my be found on the Defense News website using the link below: https://www.defensenews.com/opinion/commentary/2020/10/04/in-defense-of-the-defense-production-act/ Comments are closed.
|